Work

2388P Results from the phase Ib dose escalation of 212Pb-ADVC001 in PSMA-positive metastatic castration-resistant prostate cancer (mCRPC): The theraPb trial

Year: 2025

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2025.08.3004

Authors: A.R. Hansen, D.A. Pattison, C.L. Gan, J.C.H. Goh, S. Ngai, L. Katchel, I. Holmes, S. Baker, L. Campbell, J. Brady, P. Santoro, M. Crumbaker, M. Baronet, S. Rose, A.A. Adamovich, S. Puttick, T. Kryza, K. Kuan, A. Karmann, D.K. Wyld

Institutions: Princess Alexandra Hospital, Royal Brisbane and Women's Hospital

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415942654

FWCI: 1.159

Cites:

Cited by: 2

Related to: 10